White Paper
ICER

PDF cover

White Paper: Rebates

This white paper was developed following a December 2018 meeting of ICER’s membership program, during which leaders from the pharmaceutical and insurance industries convened to share their perspectives on how rebates grew increasingly important for their businesses, the unintended consequences they have had on drug affordability for certain patients, and possible paths forward.

View

Go Back to View More Materials